" />

SIRO in News

India's Draft on Clinical Trials Aims for Speedier Drug Approvals Feb 2018

Mr. Partha Chatterjee, Head, Clinical operations and Clinical Trial Supplies, SIRO Clinpharm provides his insight on how India's draft clinical trial rules would reduce the time it takes to approve clinical trials, and make the process more transparent.

Reproduced with permission from Pharmaceutical Law & Industry Report, 16 PLIR (February 23, 2018). Copyright 2018 by The Bureau of National Affairs, Inc. (800-372-1033) www.bna.com

Bloomberg Law - View Details

Unified LifeSphere CTMS™ and LifeSphere EDC™ Help SIRO Clinpharm Improve Clinical Trial Management Productivity and Efficiency Feb 2018

SIRO Clinpharm leverages its Clinical Trial expertise with Adoption of Unified LifeSphere CTMS™ and LifeSphere EDC™

ArisGlobal website - View Details

PR Newswire (ArisGlobal PR Partner) - View Details

Synergy between Clinical Operations and Clinical Trial Supplies for Optimum Trial Execution May 2017

A worth-while read, this article by Partha Chatterjee, Swapna Keshav and Sujay Salvi details the need for the clinical operations and clinical trial supply teams to come together to form one cohesive excellence unit with an unbroken chain of command and line of sight.

Pharmaceutical Manufacturing and Packing Sourcer (PMPS), May 2017 - View Details

Maximising the efficiency of Clinical Trial Supply Chain March 2017

In an insightful article Partha Chatterjee and Sujay Salvi detail how maximising the efficiency of clinical trial supply chain can provide a competitive advantage.

Pharma Bio World - View Details

Wearable devices – Future of healthcare; steps towards better life September 2016

Namrata Belekar writes a comprehensive article on wearable medical devices highlighting some of the most commonly used ones, their claim studies and FDA recommendations to overcome any possible harm from wrong use.

SCDM’s Newsletter: Data Basics - View Details

Interview – Express Pharma September – 2015

Dr. Vatsal Shah, Chief Operating Officer, in his interaction with Usha Sharma talks about the company's ambitious plans and some of the challenging tasks which he has undertaken to maintain the company's growth trajectory.

Express Pharma - View Details

Interview - Biotecnika Magazine Nov 2014

Biotecnika magazine, an India-based magazine focused on biotechnology industry had an opportunity to interact with SIRO Clinpharm's operational heads in tete-a-tete interview for their November 2014 issue.

Biotecnika Magazine - View Details

Playing by Protocol June 16-30, 2013

Article by Sachin Jagdale featuring inputs from Arohee Ketkar, Sr. Project Manager, Clinical Operations, SIRO Clinpharm.

Express Pharma - View Details

Clinical Research: Building Trust May 16 - 31, 2013

Cover story by Editor, Viveka Roychowdhury with interview inputs by Dr. Shubhangi Desai.

Express Pharma - View Details

Dr. Vatsal Shah from SIRO Clinpharm takes a session at the prestigious PHARMATECH conference
Dr. Vatsal Shah, global head, medical writing and pharmacovigilance, SIRO Clinpharm, was on the expert panel on the recently concluded PHARMATECH-2013.PHARMATECH is a one-of-its-kind bi-annual national conference and workshop on clinical research for postgraduate students and researchers, organized by the Department of Pharmacology & Therapeutics of the prestigious Seth GSMC & KEM Hospital in Mumbai.

View Details

Finding Alignment: Opportunities and Obstacles in the Pharma/CRO Relationship A report from the Economist Intelligence Unit 2012

The report draws on a survey of 251 senior executives from the life sciences industry as well as in-depth interviews with corporate leaders and industry experts, where Dr. Ajit Nair, President, Global Clinical Operations, SIRO Clinpharm, shares the platform renowned industry experts.

Economist Intelligence Unit - View Details

REG - Xenetic Biosciences - Phase I/IIa IV trial for ErepoXen® February 13, 2012

Xenetic Biosciences plc (LSE: XEN.L), a bio-pharmaceutical company specialising in the development of high-value differentiated biological and vaccines and novel cancer drugs, announces that, in a Phase I/IIa IV (intra venous) clinical trial, its co-development partner, the Serum Institute of India ("SIIL"), has dosed its first patient with their jointly-owned ErepoXen® candidate.

Reuters - View Details

Market Dynamics and Off Shoring Trends in Clinical Scientific Programming DIA 6th Annual Magazine, India 2011

Dr. Nimita Limaye - Senior VP & Global Head: CDM, Medical Writing, & SCEDAM
Pratibha Jalui - Alliance Manager
Girish Havildar - Scientific Programming Analyst Sourcing Partnership Lead in Global Scientific Programming, Merck Sharp & Dohme Corp.

View Details

Manuscript vs Regulatory Writing: The Key Differentiators DIA 6th Annual Magazine, India 2011

Dr. Nimita Limaye - Senior VP & Global Head: CDM, Medical Writing & SCEDAM
Dr. Lakshmi Venkatraman - PhD, Senior Manager, Publications and Safety
Dr. Wendy Battisti - PhD., Director, Regulatory Medical Writing, Johnson & Johnson Pharmaceutical Research & Development
Dr. Susan Glasser – PhD., Senior Director, Regulatory Medical Writing, Johnson & Johnson Pharmaceutical Research & Development

View Details

Enabling Success Factors to a Functional Outsourcing India-based Partnership in Statistical Programming 6th Annual Conference on Global Drug Development and Market Access

Dr. Nimita Limaye - Senior VP & Global Head: CDM, Medical Writing, & SCEDAM
Mr. Frederic Coppin - Manager, ex-US operations and sourcing partnerships, Global Scientific Programming, MSD

View Details

SIRO Clinpharm wins 'Indian Clinical Research Organisation of the Year' award September 23, 2011

Dr. Ajit Nair, President, Global Operations, accepts the award on behalf of SIRO Clinpharm, "This award has indeed recognized our efforts in the clinical research sector. As a company we have always strived for excellence in providing clinical research services to our clients. It is a pleasure to receive this prestigious award again after 2007 and I am sure SIRO's performance in the healthcare sector will bring in more such appreciations for the organization."


SIRO Clinpharm receives Indian CRO of the year award September 30, 2011

SIRO Clinpharm has been conferred with the Indian clinical research organization of the year 2011 award by Frost & Sullivan. The award was presented in Mumbai by Dr. Ajaykumar Sharma, pharmaceutical practice head, Frost & Sullivan, Middle East & India.

Centerwatch.com - View Details

SIRO Clinpharm takes initiative in medical writing training

SIRO Clinpharm a leading Contract Research Organisation (CRO) based out of India and Western and Central Eastern Europe recently announced its plans to launch CEMW (Centre of Excellence for Medical Writing), a first of its kind training institute in the field of medical writing in India.

Express Pharma - View Details

SCDM Welcomes First International Chair Wednesday, 27th October 2010

Pharmiweb.com - View Details

Indian scientist elected head of global body Monday, 25th October 2010

Times of India - View Details

SIRO Clinpharm announces launch of 'On Trak' – clinical trial management platform for its Indian operations Monday, 11th October 2010

SIRO Clinpharm, a leading Contract Research Organization (CRO) based out of India and Western and Central Eastern Europe, today announced launch of 'On Trak', its Clinical Trial Management System.

Biospectrum - View Details

SIRO joins with DreamCIS to access Korean patient pool Monday, 08th February 2010

SIRO Clinpharm has formed an alliance with South Korea-based CRO DreamCIS to expand its clinical trial offering in Asia Pacific and provide clients with more options for patient recruitment.

Outsourcing Pharma - View Details

SCDM Board of Trustee Elections Strengthen Global Focus Tuesday, October 20, 2009

Nimita Limaye, CCDM, was elected as vice chair for 2010. Limaye, vice president of CDM and medical writing at SIRO Clinpharm in Mumbai, India, is the first non-North American to serve as an officer on the SCDM Board of Trustees.

PR Log - View Details

DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm Wednesday, October 7, 2009

DBMS Consulting announced that it has successfully completed deployment of Oracle Life Sciences Applications (OHSA) Suite and Oracle E-Business Suite (EBS) for SIRO Clinpharm, one of the leading global CROs headquartered in Thane, India. OHSA offers fully automated capabilities in management of clinical trial process, clinical trial data and global adverse event reporting.

PR newswire - View Details

SIRO Clinpharm Selects Oracle's Life Sciences Applications Wednesday, February 20, 2008

SIRO Clinpharm Private Limited (SIRO), a clinical research organisation (CRO), is going to implement a new IT framework comprising Oracle's Life Sciences Applications (OLSA) and other Oracle applications running on Sun Microsystems' hardware platform.

efytimes - View Details

Siro Clinpharm offers clinical trials for Indian firms in overseas sites

The Mumbai-based Siro Clinpharm Pvt Ltd, one of the leading players in the Indian contract research industry, is planning to offer clinical trials for Indian pharmaceutical companies in overseas sites such as the US and Europe.

Pharmabiz - View Details

The Emerging CROs

The Indian CRO sector registered 70 percent growth in 2006-07 over the previous year's revenues of Rs 425 crore with exports dominating the sector.Datamonitor's R&D Strategies 2007 report points out that the drug developers have become increasingly dependent on CROs, which themselves have become increasingly globalized.


View Details